GSK0660 is a selective PPAR antagonist. GSK0660 differentially regulated 273 transcripts in TNF-treated cells compared to TNF alone. A pathway analysis revealed the enrichment of cytokine-cytokine receptor signaling. In particular, GSK0660 blocks the TNF-induced upregulation of CCL8, a chemokine involved in leukocyte recruitment. GSK0660 blocks the effect of TNF on the expressions of cytokines involved in leukocyte recruitment, including CCL8, CCL17, and CXCL10 and it may therefore block TNF-induced retinal leukostasis.
仅供研究使用。 我们不向患者出售。
化学信息
名称 | GSK0660 |
Iupac 化学名称 | GSK0660 |
同义词 | GSK-0660; GSK 0660 |
英文同义词 | GSK-0660; GSK 0660 |
分子式 | C19H18N2O5S2 |
分子量 | 418.48 |
Smile | COc1cc(ccc1NS(=O)(=O)c2ccsc2C(=O)OC)Nc3ccccc3 |
InChiKey | NDFKBGWLUHKMFY-UHFFFAOYSA-N |
InChi | InChI=1S/C19H18N2O5S2/c1-25-16-12-14(20-13-6-4-3-5-7-13)8-9-15(16)21-28(23,24)17-10-11-27-18(17)19(22)26-2/h3-12,20-21H,1-2H3 |
Cas号 | 1014691-61-2 |
MDL | MFCD12828770 |
相关CAS号 | |
外观性状 | crystalline solid |
纯度 | 98% |
存储 | 3 years -20ºCpowder |
可溶性 | Soluble in DMSO |
处理方式 | |
运输条件 | Shipped under ambient temperature as non-hazardous chemical. |
海关编码 | |
Targets | |
Mechanism | |
Cell study | |
Animal study | |
Clinical study | |